Ban circumcision among Muslims before stopping Hindu superstitions: KSE to CM

Newsroom, Apr 22: Dozens of Tablighi Jamaat members from across the country who have been successfully recovered and have now tested negative for the novel coronavirus have come forward and donate their plasma for the treatment of Covid-19 patients.

The Tablighis from Tamil Nadu were the first to take this decision. According to them, apart from helping the critically ill patients to recover from COVID-19, was to counter the ‘baseless accusations’ that Tablighis were responsible for the spread of the virus following the religious congregation of the sect held at Delhi’s Nizamuddin area last month.

Mohammad Abbas, a thirty-eight year old businessman from Tiruppur was on Sunday discharged from Coimbatore’s ESI hospital. “As soon as I got discharged, I met the district administration officials and the dean of the hospital and told them that they may contact me anytime if they needed me to donate my plasma,” Abbas was quoted as saying by an English daily.

“It has only been one day since I was discharged but I’ve already spoken to others (from the Jamaat) who have recovered and they were all ready to donate,” he added. 

Leader's call

Maulana Saad Kandhalvi, a prominent leader of Tablighi Jamaat, who has been booked by the Delhi Police for holding a religious congregation, too has appealed to coronavirus survivors to donate blood plasma for infected people.

In a letter issued on Tuesday, Saad said most of the members who were quarantined did not have any infection and they tested negative for COVID-19.

"Even from amongst the ones who tested positive for the disease, a majority of them have now undergone treatment and are now cured while I and a few others are still under quarantine.

"It is required that such people who are now cured of this disease should donate blood plasma to others who are still fighting the disease and are under treatment," he said.

He also has urged the followers of the organisation to pray at home in the month of Ramadan instead of going to mosques. 

Plasma therapy

Convalescent Plasma Therapy is an experimental procedure for COVID-19 patients.

In this therapy, the antibodies of a person who has recovered from the virus are taken and transfused into a sick person (having the virus) to help boost the person’s immune system.

The recovered COVID-19 patient’s blood develops antibodies to battle against COVID-19.

Once the blood of the first patient is infused to the second patient, those antibodies will start fighting against the coronavirus in the second person.

The process for donating plasma is similar to donating blood and takes about an hour.

Several countries around the world including the United Kingdom and the United States have also started plasma therapy trials.

In India, several states like Kerala, Gujarat and Punjab have already started using Plasma Therapy for the corona-infected patients.

Udupi, Feb 11: In a tragic incident, a 62-year-old man from Chennai died of drowning in Sri Krishna Mutt’s Madhwa Sarovar (pond) during the wee hours of Tuesday.

Police said the deceased has been identified as Capt G Sridharan.

It is suspected that Sridharan accidentally fell into the holy pond while taking a bath. The incident is said to have occurred around 4 a.m.

New Delhi, Apr 25: Karnataka Medical Education Minister Dr K Sudhakar on Saturday said that a journalist from Bangalore Urban, who has tested positive for COVID-19, is one out of 15 new cases reported in the state.

He further said that out of the 15 new coronavirus cases, six each are from Bangalore Urban and Belagavi and one each from Mandya, Chikkaballapura and Dakshin Kannada. The state's tally is now 489.

"#COVID19 Update: From 5 pm, 24th April till 12 noon today. A total of 489 cases, 15 positives, 18 deaths & 183 discharges," Sudhakar tweeted.

India's total number of coronavirus positive cases has climbed to 24,506 including 18,668 active cases, 5,063 cured/discharged/migrated and 775 deaths, the Ministry of Health and Family Welfare said today.